IGM Financial (TSE:IGM) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?
IGM Financial Inc operates as a wealth and asset management company in Canada. It operates through Wealth Management and Asset Management segments. The Wealth Management segment offers investments ...
Michelle McDonald clearly remembers her first day with the IGM Financial Inc. family of companies. After graduating from college, she worked for two different banks over a two-year period and says ...
IGM Financial Inc. (TSE:IGM – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday .The stock has a 200-day moving average of C$43.50 and traded as high ...
Assets Under Management and Advisement (AUM&A) represents the consolidated AUM and AUA of IGM Financial's core businesses IG Wealth Management and Mackenzie Investments. In the Wealth Management ...
With CAD 249.1 billion in core AUM at the end of October 2024, IGM Financial is the largest non-bank-affiliated domestic asset manager in the Canadian market. The largest Canadian banks and ...
As a dedicated volunteer member of the Black Business Resource Group (BRG) for the IGM Financial Inc. family of companies, Lape Adeniran says she wanted to take a fresh approach to how Black ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on IGM Biosciences (IGMS – Research Report), with a price target of $1.50. See what stocks are receiving ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
People are getting more pessimistic about their own financial outlook for the year ahead, according to the latest Survey of Consumer Expectations from the Federal Reserve Bank of New York.
In a report released today, Michael Ulz from Morgan Stanley maintained a Sell rating on IGM Biosciences (IGMS – Research Report), with a price target of $2.00. See what stocks are receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results